Busca
Exibindo 2341 - 2370 de 2726
Sociologist and Fiocruz president, Nísia Trindade Lima, presented last Friday (October 8th) the conference Pandemic and Social Inequalities: Challenges for Global Health. The event was part of the Global Health Colloquium Series, a biannual series of lectures by Princeton University's Program in Global Health. Nísia thanked the university and Brazil Lab for the invitation, a hub that connects researchers and professors interested in public management in the country. The mediation was by Arbela Griner, postdoctoral fellow of the Program and event organizer.
Values, total social fact, and…
Article
A study led by the Center for the Integration of Data and Knowledge on Health (Cidacs/Fiocruz Bahia) suggests that C-sections may be associated with a higher risk of infant mortality, with the exception of cases in which a medical indication is clear on this procedure, which is popularly known as “cesarean” in Brazil.
Photo: Courtesy
Using data collected and provided by the Ministry of Health on more than 17 million births in Brazil between 2012 and 2018, researchers from Brazil and from the United Kingdom observed that in the group with a low indication of C-section, this procedure was…
Article
After a one-year break due to the restrictions caused by the COVID-19 pandemic, the Fiocruz in Antarctica (Fioantar) project resumed its scientific excursions into the continent with a new departure this Wednesday morning (10/13). After a week of quarantine with actions to fight COVID-19, including diagnostic tests before and during the period, the Ary Rongel oceanographic support ship set sail to the Comandante Ferraz Antarctic Station carrying researcher Lucas Moreira. In November, three other Fioantar researchers - Maria Ogrzewalska, Harrison Magdinier Gomes, and Maithê Magalhães - will be…
Article
The ambassador of Botswana to Brazil, Tebogo Montshome, visited Fiocruz last Thursday (October 7th). She decided to get to know the Foundation while visiting Rio de Janeiro to identify areas of possible cooperation between her country and the institution. Greeted by the Vice-President of Production and Innovation in Health, Marco Krieger, Montshome was particularly interested in staff training, research and production of drugs and vaccines.
Marco Krieger, Tebogo Montshome, Sethunya Sedimo and Augusto Paulo Silva (Photo: Peter Ilicciev)
The ambassador was accompanied by the embassy's…
Article
On Thursday (September, 30th), the project for the installation of the Pharmaceutical Plant in Maputo, Mozambique capital, was concluded. The announcement was made in a joint statement by the Brazil and Mozambique governments and is the result of the technology transfer mission and partnership with the Institute of Technology in Medicines (Farmanguinhos/Fiocruz).
"We are finishing this important project with the merit of having left the factory producing, teams trained, and a set of technologies transferred that are now part of the initial Mozambican Drug Society portfolio", said the…
Article
Fiocruz will be part, starting next week, of a Phase 3 international multicenter study with the drug Molnupiravir, manufactured by the pharmaceutical company MSD. The goal is to verify its efficiency to prevent the COVID-19 spread and transmission among people exposed to the Sars-CoV-2 virus. The study will occur simultaneously in seven centers in Brazil, two of which are under the Fiocruz responsibility: Mato Grosso do Sul and Rio de Janeiro. The coordination is under the responsibility of researchers Julio Croda and Margareth Dalcolmo.
To evaluate the Molnupiravir use as post-exposure…
Article
A cooperation that dates back to the beginning of the last century and that has been renovated and expanded over the decades was celebrated last Thursday (October 14th), with the visit of Portugal’s assistant secretary of Health, António Lacerda Sales, to Fiocruz. Accompanied by the Secretary of State of the Portuguese Communities, Berta Nunes, and by ambassador Luís Faro Ramos, among other members of the delegation, Sales was received by president Nísia Trindade Lima at the International Auditorium of the Sergio Arouca National School of Public Health (ENSP/Fiocruz), where they emphasized…
Article
Last Thursday (28 October) Fiocruz signed, during a ceremony that took place at the headquarters of AstraZeneca, in Cambridge, United Kingdom, a joint declaration of commitment for the acquisition of Active Pharmaceutical Ingredient (API) with the goal of producing 60 million doses of the COVID-19 vaccine (recombinant) in order to make up the deliveries of the Foundation for 2022. The commitment signed by the institutions aims to guarantee wide availability of vaccine doses for the first semester. With the guarantee of the imported ingredient, Fiocruz will be able to deliver, through the…
Article
The team of the Viral Vaccines Laboratory of the National Institute for Quality Control in Health (INCQS/Fiocruz), which works with immunobiological drugs against rabies (LVV-Raiva), is participating in the second phase of an international study to replace potency assays in anti-rabies vaccines, traditionally made using mice for over 50 years.
Under code BSP148 and funded by the European Directorate for the Quality of Medicines and Healthcare (EDQM), an institution of the Council of Europe in charge of the issuing of the European Pharmacopoeia, the research aims to validate the immuno-…
Article
Ten years after its signing, the Rio Political Declaration on Social Determinants of Health is more relevant than ever, as shown by the impacts of the COVID-19 pandemic in the world. To celebrate the document’s tenth anniversary and evaluate the approaches adopted since, two webinars held last Thursday (21 October) brought together many actors that were crucial for the negotiations that culminated in the declaration and for the quest for its implementation. While the World Health Organization (WHO) organized the seminar Actions on the Social Determinants of Health Equity, opened by the…
Article
A new study published in Nature Communications last Thursday (28/11) shows that two doses of the AstraZeneca vaccine, produced in Brazil by Fiocruz, provide high protection against the Gamma variant in people above 60 years old. Based on São Paulo, the research shows that the second dose increases protection against death by about 30% when compared to the first dose, reaching an effectivity of 93.6%. Carried out by 20 researchers in Brazil, the United States and Spain, the study called Effectiveness of the ChAdOx1 vaccine in older adults during the circulation of the Gamma variant in São…
Article
When Fiocruz joined the small summit of guest countries of the Global Sustainable Technology and Innovation Community (G-STIC) in 2018, the world still did not know Sars-CoV-2. Now, while the world population takes the vaccine for COVID-19, the fifth edition of the annual conference (the fourth with the participation of the Foundation), bets on a hybrid participation model from October 24th to 26th. The agenda includes both virtual and on-site sessions looking for new technological solutions to serve the society that are environmentally friendly and aimed at 9 of the 17 Sustainable…
Article
Production of the Fiocruz Active Pharmaceutical Ingredient (API) for COVID-19 vaccines is ongoing and is now moving on to a new and important phase of the process. Two pre-validation batches of the product manufactured by Fiocruz have been approved in all in-house quality tests and are now on their way to an external quality control at USA laboratories. At these labs, the samples will go through a complex testing process that involves 14 tests in addition to those carried out in Brazil, the longest of which takes 56 days to complete. This set of tests compare Brazilian and foreign APIs,…
Article
Would it be possible to establish a new food model without the large producers' participation? Finding this answer is an ongoing global challenge and resounded in the seminar Food security, health and pandemics in United Nations events, organized by the Fiocruz Global Health Center (CRIS/Fiocruz). Divergent analyses and opinions revealed behind the scenes of international decisions on hunger programs and inspired empathy in provocative, necessary and urgent reflections.
"Is it possible to think of an alternative food system without the large corporations' participation? In Chile, even Coca-…
Article
The first dose protects, but immunization requires a second dose and varies according to the age group and the time interval between doses. These are some conclusions of the pre-publication study that evaluated the effectiveness of the first dose of the AstraZeneca/Fiocruz vaccine against symptomatic cases of COVID-19 in the population of Complexo da Maré, in Rio de Janeiro (RJ). A 42.4% protection against symptomatic cases was estimated 21 days after the first dose of the vaccine. “It has a good result for containing symptomatic cases, but the second dose is essential to guarantee more…
Article
“One mistake, one correction”: according to Carlos Morel, a researcher from the Brazilian state of Pernambuco, former Fiocruz president and current coordinator of the Center for Technological Development in Health (CDTS), this is how the world works. Last Tuesday (23 November), after attending the first meeting of the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), a group formed by the World Health Organization (WHO), Morel defended the mass sequencing of circulating virus, an idea he hopes to gain traction with the new group. “It is important to sequence what’s out…
Article
In another huge step to the internationalization of education, Fiocruz updated the ordinance that regulates the dual-degree stricto sensu graduation program regime with foreign higher education institutions regarded as of strategic relevance for the Foundation, no. 508, of 2021. The initiative allows students to get dual-degrees or titles in master's and doctorate's degrees. With this regime, when finishing the program, the student receives a diploma from a foreign institution that is part of the cooperation, along with a Fiocruz diploma.
The cooperation convention establishes the conditions…
Article
There are a lot of statements, and a lot of commitments as well, but there is a lack of distinction of responsibilities and of the obligation in fulfilling the goals set, which hinders the operation of the G20. That is what the participants in the latest Advanced Seminar of the Fiocruz Global Health Center (CRIS/Fiocruz) point out. The G-20 Webinar: What we should expect from the richest people in the world in global and planetary health? analyzed the conclusions of the summit of the 19 countries that have the world’s main economies and the European Union.
For Paulo Esteves,…
Article
Sociologist and president of Fiocruz, Nísia Trindade Lima was appointed for The World Academy of Sciences for the advancement of science in developing countries (TWAS). The appointment was in the Academy’s General Meeting, on November 1st, as part of its 15th general conference.
Nísia is one of the 20 women who were appointed, in a total of 58 new members (Photo: Reproduction)
TWAS has the goal of bringing different scientific societies of developing countries closer, to promote its sustainable prosperity through science and technology, supporting researchers by granting scholarships and…
Article
With two actions this week, Fiocruz became even more engaged in the fight against Hansen's, a neglected disease that had its situation aggravated during the COVID-19 pandemic. On Wednesday (11/17), the Foundation signed a Cooperation Agreement for joining the global campaign Don't Forget Hansen's Disease, with the state government and other partners, in addition to lighting the castle with purple at night as one of the actions to raise awareness. This Thursday (11/18), Fiocruz deepened the debate during the 1st Symposium on Neglected Diseases Fiocruz-Novartis: focus on Chagas and Hansen's…
Article
Severe cases of COVID-19 are related to the ageing of the immune system and to acute immunodeficiency. It is what the new study led by the Oswaldo Cruz Institute (IOC/Fiocruz) and by the Federal University of Rio de Janeiro (UFRJ) shows, published in the academic journal Journal of Infectious Diseases.
By analyzing blood samples of patients that have been hospitalized with the disease, the researchers detected signs of hyperactivity, exhaustion and ageing of the defense cells known as T helper cells. According to scientists, the data shows loss of responsiveness of these cells in severe COVID…
Article
In 2018, the king of the Yoruba people, Ooni of Ife, Oba Adeyeye Enitan Babatunde Ogunwus, visited Fiocruz and introduced the idea of a partnership in the field of traditional medicine and integrative health practices. Because of the COVID-19 pandemic, the conversation was stalled, but it was resumed this Wednesday (November 24th) with a visit of a delegation from the Palace of Ife to the Foundation.
(Photo: Pedro Paulo Gonçalves)
The delegation was led by the kings Ajero of Ijero (from the Ekiti state) and Apomu of Alapomu (from the Osun state), along with the Oduduwa Heritage…
Article
Last Thursday (25 November) the Oswaldo Cruz Foundation, by means of its Immunobiological Technology Institute (Bio-Manguinhos/Fiocruz), submitted to the Brazilian Health Regulatory Agency (Anvisa) a request of post-registration alteration of its COVID-19 vaccine (recombinant), asking to include the Institute as the manufacturing unit of the Active Pharmaceutical Ingredient (API). Check out this 360º view of the production area for the Brazilian API for vaccines, at Fiocruz.
Five batches of Brazilian API have been produced, and four of them are currently going through analytical…
Article
At a moment in which the world is watching a new peak of COVID-19 cases, preliminary analysis of a study on safetey and immunogenicity indicate that the use of the AstraZeneca vaccine as a booster shot increases the immune response against the variants of concern Beta, Delta, Alpha, and Gamma. An analysis made separately with samples of the research also shows an increased response of antibodies against the Omicron variant, which is behind the new wave of the disease.
Preliminary analysis of a study indicate that the use of the AstraZeneca vaccine as a booster shot increases the immune…
Article
Science, technology and innovation to create resiliency, recover the planet from the impacts of COVID-19 and prepare it to face future health crises, including the ones resulting from environmental problems. This was the focus of the Global Sustainable Technology and Inovation Conference (G-Stic), an international reference in the debate that relates science, technology and innovation to the 2030 Agenda, which took place in Dubai from January 17th to 19th, 2022. Fiocruz takes part in it since 2019, through Fiocruz Strategy for the 2030 Agenda (EFA 2030), being invited by G-Stic to be a cohost…
Article
We all had some degree of hope that the end of 2021 and the beginning of 2022 would bring us the much-awaited retraction of the pandemic. However, the emergence of the new Omicron variant dragged us away from the end of the tunnel we were longing for. Many countries, including some with powerful health systems, excellent living conditions, and high levels of vaccination, are hitting record numbers of contagions every day.
So far, the challenge on the horizon for 2022 is to overcome the pandemic and the immense sanitary and socio-economic inequality, achieve social and economic recovery…
Article
The ties between Fiocruz and the United States Consulate in Rio de Janeiro should become closer next year. On 12/16, the consul Jacqueline Ward and the president of Fiocruz, Nísia Trindade Lima, met at the Official Residence. On the agenda, scientific cooperation between Brazilian and American institutions, the XVI National Malaria Research Meeting and a parallel symposium organized by the Foundation and the National Institute of Allergy and Infectious Diseases/National Institutes of Health of the United States (NIAID-NIH), with the international experts' participation, such as Anthony Fauci…
Article
As with other COVID-19 immunizers, a booster dose of AstraZeneca vaccine is also required after the complete vaccination schedule. This is indicated by a new study involving Brazil and Scotland, and published in the scientific journal The Lancet on Monday (12/20). The research, of which Fiocruz is part, shows the decrease in vaccine protection over time and in face of the new variants’ emergence.
The assessment, carried out at a time of intense variants of concern circulation and the Omicron emergence, reinforces the importance of the pandemic dynamics surveillance. The follow-up, which is…
Article
The first edition of the bulletin on the COVID-19 vaccines' effectiveness in the Brazilian population, from Fiocruz's Vigivac project, was published on Thursday (12/9). The report, which presents analyses of the four vaccines administered in Brazil from January to October 2021, points out that all of them confer a great reduction in the risk of infection, hospitalizations, and death from COVID-19. Considering serious outcomes (hospitalization or death) in individuals aged 20-80 years, protection ranged from 83% to 99% for all immunizers. In the population under 60, all vaccines showed…
Article
A project resulting from a partnership between the Ministry of Health, Fiocruz, Lacen-PR, and the Federal University of São Paulo (Unifesp) was one of those selected by the U.S. Centers for Disease Control and Prevention (CDC) for funding, as part of the creation of two global networks aimed at fighting antimicrobial resistance. With Ana Paula Assef, head of the Hospital Infection Research Laboratory (LAPIH) at the Oswaldo Cruz Institute (IOC/Fiocruz), as the principal investigator, the Strengthening Brazilian Surveillance System for Antimicrobial Resistance program aims to reinforce the…
Article